Compare MAA & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAA | HLN |
|---|---|---|
| Founded | 1977 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Package Goods/Cosmetics |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 43.7B |
| IPO Year | N/A | N/A |
| Metric | MAA | HLN |
|---|---|---|
| Price | $126.55 | $10.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $149.33 | N/A |
| AVG Volume (30 Days) | 698.8K | ★ 8.2M |
| Earning Date | 04-29-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.87% | 1.76% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.85 | $7.04 |
| Revenue Next Year | $3.13 | $4.58 |
| P/E Ratio | ★ $35.71 | $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $125.62 | $8.71 |
| 52 Week High | $169.42 | $11.42 |
| Indicator | MAA | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 34.07 | 45.92 |
| Support Level | $125.75 | $10.23 |
| Resistance Level | $136.72 | $11.35 |
| Average True Range (ATR) | 2.35 | 0.15 |
| MACD | -0.65 | -0.03 |
| Stochastic Oscillator | 9.41 | 31.48 |
Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.